SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-16-436354
Filing Date
2016-01-25
Accepted
2016-01-25 09:08:10
Documents
3
Group Members
LAUREL ACQUISITION INC.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 8 TO SCHEDULE TO d131414dsctota.htm SC TO-T/A 26413
2 EXHIBIT (A)(1)(Q) d131414dex99a1q.htm EX-99.(A)(1)(Q) 8645
3 GRAPHIC g131414g52k01.jpg GRAPHIC 32979
  Complete submission text file 0001193125-16-436354.txt   82251
Mailing Address 33 LOCKE DRIVE MARLBOROUGH MA 01752
Business Address 33 LOCKE DRIVE MARLBOROUGH MA 01752 508-756-1212
Ocata Therapeutics, Inc. (Subject) CIK: 0001140098 (see all company filings)

IRS No.: 870656515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-79462 | Film No.: 161357610
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2-5-1, NIHONBASHI-HONCHO CHUO-KU TOKYO M0 103-8411
Business Address 2-5-1, NIHONBASHI-HONCHO CHUO-KU TOKYO M0 103-8411 81-3-3244-3231
Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

IRS No.: 132971791
Type: SC TO-T/A